U.S. 503A Compounding Pharmacy Packaging Companies and Developments

Date : 30 October 2025

The U.S. 503A compounding pharmacy packaging market is growing rapidly and is expected to generate hundreds of millions in revenue from 2025 to 2034, contributing to advancements in sustainable transportation. Key players in the market are focusing on mergers and acquisitions to develop advanced technology for manufacturing 503A compounding pharmacy packaging, which will drive the market’s growth during this period.

U.S. 503A Compounding Pharmacy Packaging Market Players

503A Compounding Pharmacy Packaging Market Companies

  • BioCare, Inc.
  • Triangle Compounding
  • Fagron
  • B. Braun SE
  • Pencol Specialty Pharmacy
  • Vertisis Custom Pharmacy
  • Optum Inc
  • Pavilion Compounding Pharmacy, LLC.
  • Village Compounding Pharmacy
  • McGuff Compounding Pharmacy
  • Wedgewood Pharmacy
  • Seco Industries
  • Yourway
  • CareFirst Specialty Pharmacy
  • McGuff Compounding Pharmacy
  • Village Compounding Pharmacy
  • Pavilion Compounding Pharmacy, LLC

Latest Announcements by 503A Compounding Pharmacy Packaging Industry Leaders:

  • On January 07, 2025, U.S. FDA published guidelines on compounding with bulk drug substances for 503A pharmacies and 503B outsourcing facilities on January 7, 2025. While the FDA continues to assess products for inclusion on lists of materials that can be used in medication compounding, these guidelines offer security and assistance to pharmacies and outsourcing facilities that employ specific types of bulk drug substances.
  • In October 2024, The American Pharmacists Association stated that patients depend on compounding pharmacies, particularly those who require specialized prescription, are unable to tolerate a certain medication, or require medications that are currently in low supply.

New Advancements in 503A Compounding Pharmacy Packaging Industry

  • In August 2024, Aleata Postell, Walmart's head of specialty pharmacy and group director of pharmacy business development, talked about the company's new autoimmune-focused specialty pharmacies of the community (SPOCs).According to Postell, these pharmacies serve patients with more complicated requirements by bringing high-touch specialty pharmacies into nearby areas.
  • In February 2025, Empower, healthcare manufacturing company, revealed the launch of the unified the 503A compounding pharmacy, 503B outsourcing facilities and refreshed corporate logo under a single Empower brand. With a streamlined formulary and easy access to Empower's premium drugs, the unified brand will simplify services for patients, doctors, and pharmacists.The Empower company’s 380,000-square-foot production facility and more than 1,100 people are committed to offering individualized, reasonably priced, and easily accessible healthcare solutions.

Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com